Bayer sells Dr. Scholl's foot care business to Boston firm
Posted July 22, 2019 7:00 am
BERLIN (AP) - German pharmaceutical and chemical company Bayer AG says U.S. investment firm Yellow Wood Partners will buy its Dr. Scholl's foot care business for $585 million.
Bayer said Monday that the sale will enable it to "focus on building its core over-the-counter brands." It said that Yellow Wood Partners, based in Boston, will create a stand-alone company and plans to invest in all aspects of the business.
The transaction, which requires approval from competition authorities, is expected to close in the fourth quarter.
Dr. Scholl's, which had sales of $234 million last year, makes insoles, inserts and a variety of foot care and treatment products.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.